Breaking News
11 hours ago
Vaibhavi M.
Thermo Fisher enrolls the first patient in its PPD CorEvitas Obesity Registry to study real-world obesity treatment outcomes.
Vaibhavi M.
Milestone Pharma secures EMA acceptance of its MAA for etripamil, a patient-administered nasal spray for PSVT.
Vaibhavi M.
Outlook Therapeutics appoints Laura Cantrell as VP to lead corporate strategy, partnerships, and business development efforts.
Vaibhavi M.
Jazz announces practice-changing Phase 3 data for Ziihera, demonstrating improved survival in HER2-positive gastroesophageal cancer.
Vaibhavi M.